Dr. John Hubanks

Dr. John Hubanks
Dr. Hubanks specializes in the diagnosis and treatment of a variety of urologic conditions including BPH/enlarged prostate and minimally invasive robotic surgery. He completed a Urology Resident Preceptorship in Robotic Surgery at The Ohio State University Center for Minimally Invasive Surgery, Columbus, Ohio. About Dr. Hubanks Dr. Hubanks’ work has been published in several important scientific publications: Hubanks JM, Boorjian SA, Frank I, Rangel LJ, Gettman MT, Karnes RJ. The presence of extraprostatic extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Accepted for publication, Urologic Oncology, September 2012. Hubanks JM, Umbreit EC, Karnes RJ, Myers RP. Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series. European Urology 2012; 61: 878-884. Roth CC, Hubanks JM, Bright BC, Heinlen JE, Donovan BO, Kropp BP, Frimberger D. Occurrence of urinary tract infection in children with significant upper urinary tract obstruction. Urology 2009; 73: 74-8.
Medical School:

University of Oklahoma College of Medicine


Mayo School of Graduate Medical Education

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only